Iowa 2023-2024 Regular Session

Iowa Senate Bill SSB1096

Introduced
1/30/23  
Introduced
1/30/23  

Caption

A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors, providing for immunity; and providing penalties.(See SF 508.)

Impact

This bill significantly impacts state law by amending existing regulations; it modifies sentencing guidelines for controlled substance offenses and adds specific clauses addressing possession and delivery to minors. Under SSB1096, individuals found guilty of crimes involving fentanyl-related substances can expect to face enhanced penalties, including multiples of the standard sentence duration for violations that result in injury or death. This change aims to strengthen the legal framework surrounding the handling of controlled substances, moving towards a more punitive approach to deter drug offenses in Iowa.

Summary

Senate Study Bill 1096 addresses various legal aspects related to controlled substances, particularly focusing on the handling of fentanyl and other controlled substances. The bill seeks to increase penalties associated with the manufacture, delivery, or possession of these substances, especially when minors are involved. Notably, it establishes more severe repercussions for actions leading to serious bodily harm or fatalities that occur during drug-related violations. These enhancements aim to deter the dangerous distribution of substances and are part of a broader effort to combat the opioid crisis in the state.

Contention

While the bill aims to strengthen public health and safety by addressing the opioid epidemic, some contention arises around the implications of doubling sentencing durations for certain offenses and its focus on minors. Critics may argue that such stringent penalties could disproportionately affect individuals facing drug addiction issues rather than addressing the root causes of substance abuse. There is also concern regarding the balance between enforcement and healthcare approaches in dealing with drug-related crises in the community.

Companion Bills

IA HSB104

Related A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors, providing for immunity; and providing penalties.(See HF 595.)

IA HF595

Replaced by A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors; providing for immunity; and providing penalties. (Formerly HSB 104.) Effective date: 07/01/2023.

IA SF508

Replaced by A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors; providing for immunity; and providing penalties.(Formerly SSB 1096.)

Similar Bills

IA HSB104

A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors, providing for immunity; and providing penalties.(See HF 595.)

IA HF595

A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors; providing for immunity; and providing penalties. (Formerly HSB 104.) Effective date: 07/01/2023.

IA SF508

A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors; providing for immunity; and providing penalties.(Formerly SSB 1096.)

IA HF2296

A bill for an act relating to the provision of harm reduction vending machines.

RI H5615

Revises sections of the uniform controlled substances act to remove specific opioid dosage requirements, revises the uniform controlled substances act in accordance with current standards of professional practice and would repeal chapter 37.4 of title 5.

CA AB1037

Public health: substance use disorder.

OR SB236

Relating to controlled substances.

CT SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.